Table 3. Cytogenetic response in... | American Society of Hematology

Table 3.

Cytogenetic response in patients with confirmed diagnosis of accelerated phase

Cytogenetic response^3-150	Total n = 181 n (%)	400-mg dose group n = 62 n (%)	600-mg dose group n = 119 n (%)
Major^3-151	43 (24)	10 (16)	33 (28)
95% CI	17.8-30.6	8.0-27.7	19.9-36.7
Complete	30 (17)	7 (11)	23 (19)
Partial	13 (7)	3 (5)	10 (8)
Minor	12 (7)	5 (8)	7 (6)
Minimal	31 (17)	9 (15)	22 (18)
No response	82 (45)	36 (58)	46 (39)
Not evaluated	13 (7)	2 (3)	11 (9)

Cytogenetic response^3-150	Total n = 181 n (%)	400-mg dose group n = 62 n (%)	600-mg dose group n = 119 n (%)
Major^3-151	43 (24)	10 (16)	33 (28)
95% CI	17.8-30.6	8.0-27.7	19.9-36.7
Complete	30 (17)	7 (11)	23 (19)
Partial	13 (7)	3 (5)	10 (8)
Minor	12 (7)	5 (8)	7 (6)
Minimal	31 (17)	9 (15)	22 (18)
No response	82 (45)	36 (58)	46 (39)
Not evaluated	13 (7)	2 (3)	11 (9)

F3-150

Cytogenetic response defined by prevalence of Ph⁺ metaphases: 0%, complete; 1% to 35%, partial; 36% to 65%, minor; 66% to 95%, minimal; greater than 95%, none.

F3-151

Major cytogenetic response indicates complete or partial response.

View Large

This Feature Is Available To Subscribers Only